A share of Kronos Bio Inc (NASDAQ:KRON) closed at $1.11 per share on Friday, up from $1.06 day before. While Kronos Bio Inc has overperformed by 4.72%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KRON fell by -50.22%, with highs and lows ranging from $2.84 to $0.73, whereas the simple moving average fell by -27.25% in the last 200 days.
On September 14, 2022, Berenberg started tracking Kronos Bio Inc (NASDAQ: KRON) recommending Buy.
Analysis of Kronos Bio Inc (KRON)
Kronos Bio Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -53.39% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.46, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and KRON is registering an average volume of 236.36K. On a monthly basis, the volatility of the stock is set at 12.13%, whereas on a weekly basis, it is put at 16.64%, with a gain of 38.80% over the past seven days. Furthermore, long-term investors anticipate a median target price of $9.00, showing growth from the present price of $1.11, which can serve as yet another indication of whether KRON is worth investing in or should be passed over.
How Do You Analyze Kronos Bio Inc Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 33.66%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 35.66% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in KRON shares?
The recent increase in stakes in KRON appears to be a result of several institutional investors and hedge funds increasing their positions. BVF Partners LP’s position in KRON has increased by 3.25% in the first quarter. The company now owns 2,905,043 shares of the stock, with a value of $2.54 million, following the purchase of 91,558 additional shares during the last quarter. During the last quarter, the company picked up 0 additional shares for a total stake of worth $1.53 million, bringing number of shares owned by the company to 1,752,745.
KRON shares are owned by institutional investors to the tune of 35.66% at present.